Results 121 to 130 of about 23,499 (227)

Expression, purification, and molecular characterization of plasmodium falciparum FK506-binding protein 35 (PfFKBP35)

open access: yes, 2007
The immunosuppressive drug FK506 binds its targets FK506-binding protein (FKBP) family and modulates cellular processes. Recent studies demonstrated that FK506 shows anti-malaria effects.
Kang, Cong Bao   +4 more
core   +1 more source

The immunosuppressant FK506 inhibits amino acid import in Saccharomyces cerevisiae

open access: yes, 1993
The immunosuppressants cyclosporin A, FK506, and rapamycin inhibit growth of unicellular eukaryotic microorganisms and also block activation of T lymphocytes from multicellular eukaryotes. In vitro, these compounds bind and inhibit two different types of
Hall, M. N.   +6 more
core  

Characterization of FK506 Biosynthetic Intermediates Involved in Post-PKS Elaboration

open access: yes, 2016
The post-PKS modification steps of FK506 biosynthesis include C9-oxidation and 31-O-methylation, but the sequence of these reactions and the exact route have remained unclear.
Si-Kyu Lim (1346865)   +7 more
core   +1 more source

Tacrolimus (FK506) Cerebral Blindness Following Translplantation

open access: yes, 1995
Tacrolimus (FK506) is an immunosuppressant agent in use since 1984 to prevent graft rejection following transplantation. It is presumed similar to cyclosporine in its mode of action and its toxicity.
Todd C. Geis, MD; Nancy J. Newman, MD
core  

Combination of hydrotropic nicotinamide with nanoparticles for enhancing tacrolimus percutaneous delivery

open access: yesInternational Journal of Nanomedicine, 2016
Wenhui Pan, Mengyao Qin, Guoguang Zhang, Yueming Long, Wenyi Ruan, Jingtong Pan, Zushuai Wu, Tao Wan, Chuanbin Wu, Yuehong Xu Department of Pharmaceutics, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, People’s Republic of ...
Pan W   +9 more
doaj  

FK506: the promise and the paradox

open access: yesClinical and Experimental Immunology, 1991
openaire   +3 more sources

PEG-fusion of viable sciatic nerve isografts restores axonal structure and behavioral recovery after segmental-loss sciatic nerve injuries in Lewis rats. [PDF]

open access: yesPLoS One
Yang CZ   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy